Page 24 - Read Online
P. 24

Page 10 of 13                        Matsuoka et al. J Cancer Metastasis Treat 2018;4:6  I  http://dx.doi.org/10.20517/2394-4722.2017.85

               CONCLUSION
               In conclusion, new genetic technologies are improving the detection of micrometastasis in the peritoneum,
               although conventional cytology is still the gold standard for PLC. The development of genetic PLC based on
               comprehensive genomic analysis could help us to identify patients who should be treated completely with
               multimodal therapy in addition to radical surgery, and will be very relevant to all sorts of clinical decision-
               making.



               DECLARATIONS
               Acknowledgments
               We would like to thank our colleagues in our laboratory for helpful discussions. We apologize for not being
               able to cite all the relevant publications due to space limits.

               Authors’ contributions
               Designed this review: Yashiro M, Matsuoka T
               Wrote and edited the manuscript: Matsuoka T

               Financial support and sponsorship
               None.


               Conflicts of interest
               There are no conflicts of interest.

               Patient consent
               Not applicable.

               Ethics approval
               Not applicable.

               Copyright
               © The Author(s) 2018.


               REFERENCES
               1.   Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol
                   Biomarkers Prev 2016;25:16-27.
               2.   Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality
                   worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
               3.   Kagawa S, Shigeyasu K, Ishida M, Watanabe M, Tazawa H, Nagasaka T, Shirakawa Y, Fujiwara T. Molecular diagnosis and therapy for
                   occult peritoneal metastasis in gastric cancer patients. World J Gastroenterol 2014;20:17796-803.
               4.   Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, Fushida S, Fujimura T, Nishimura G, Miwa K. Intraoperative
                   lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999;178:256-62.
               5.   Higaki E, Yanagi S, Gotohda N, Kinoshita T, Kuwata T, Nagino M, Ochiai A, Fujii S. Intraoperative peritoneal lavage cytology offers
                   prognostic significance for gastric cancer patients with curative resection. Cancer Sci 2017;108:978-86.
               6.   Kodera Y, Ito S, Mochizuki Y, Ohashi N, Tanaka C, Kobayashi D, Kojima H, Matsui T, Kondo K, Fujiwara M. Long-term follow up of
                   patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study. Gastric Cancer 2012;15:335-7.
               7.   Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1-19.
               8.   Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of
                   TNM. Ann Surg Oncol 2010;17:1471-4.
               9.   De Andrade JP, Mezhir JJ. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review. J Surg
                   Oncol 2014;110:291-7.
               10.  Yoneda A, Taniguchi K, Torashima Y, Susumu S, Kanetaka K, Kuroki T, Eguchi S. The detection of gastric cancer cells in intraoperative
                   peritoneal lavage using the reverse transcription--loop-mediated isothermal amplification method. J Surg Res 2014;187:e1-6.
   19   20   21   22   23   24   25   26   27   28   29